2BB score and signals
Aardvark Therapeutics, Inc.’s current 2BB score is 20 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 26 | Weak |
| Quality | 60 | Strong |
| Risk | 45 | Moderate |
2BBBullish & Bearish
Aardvark Therapeutics, Inc. (AARD) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 20 out of 100.
Aardvark Therapeutics, Inc.’s current 2BB score is 20 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 26 | Weak |
| Quality | 60 | Strong |
| Risk | 45 | Moderate |
| Founded | 2017 |
| Employees | 28 |
| 52-week range | $3.35 – $17.94 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-11 | — | -0.7813 | — | $0.00 |
| 2026-08-19 | — | -0.8917 | — | $0.00 |
| 2026-05-07 | -0.99 | -0.8948 | $0.00 | $0.00 |
| 2026-03-23 | -0.81 | -0.8494 | $0.00 | $0.00 |